--- the subscriber area has no ads and those above are not selected or endorsed by this site ---


ExOne schedules 1Q16 report ?3


ExOne has scheduled the report on its first quarter for the evening of Tuesday, May 11.  Average analyst estimates are for a loss of 33 cents per share on revenue of $9.1M.  Average current quarter projections are for sales of $11.5M. 

Everything I've seen reinforces my opinion that current pricing is the result of short squeeze.  The rebate rate is now down to 10% and most of the upward surges in XONE have been counter-market movements.  Hopefully management is getting its act together and the business is improving, but I would need hard evidence that the company can become profitable within a year in order to allay my wariness of the stock.